Novartis

Novartis brings augmented reality tech to ASCO to simulate leukemia patient experience
Fierce Pharma
Thu, 05/30/24 - 11:32 am
Novartis
ASCO 2024
augmented reality
patients
CML
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins
BioSpace
Tue, 05/28/24 - 10:47 am
Novartis
kidney disease
atrasentan
IgA nephropathy
Fabhalta
Novartis Meets Offer Conditions To Buy MorphoSys In EUR 68/shr Cash Deal
NASDAQ
Fri, 05/17/24 - 11:24 am
Novartis
MorphoSys
M&A
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Why selling to Novartis made sense for Mariana
BioPharma Dive
Sun, 05/5/24 - 11:37 pm
Novartis
Mariana
M&A
JPMHC 2024
Novartis further entrenches into radiopharma with $1B Mariana buy
Fierce Biotech
Thu, 05/2/24 - 11:41 am
Novartis
M&A
Mariana Oncology
radiopharmaceuticals
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech
Tue, 04/30/24 - 08:27 am
Novartis
radioligand
radiopharmaceuticals
PeptiDream
peptide-drug conjugate
Novartis names ex-BMS CEO Caforio as chair amid strong Q1
Pharmaphorum
Tue, 04/23/24 - 10:29 am
Novartis
earnings
Giovanni Caforio
Bristol Myers Squibb
Novartis touts surrogate endpoint win, nabs priority review for Fabhalta in IgAN
Fierce Pharma
Mon, 04/15/24 - 09:32 pm
Novartis
Fabhalta
IgAN
priority review
FDA
Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing
Fierce Biotech
Fri, 04/12/24 - 11:23 am
Novartis
MorphoSys
pelabresib
myelofibrosis
M&A
BET inhibitor
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
BioSpace
Thu, 04/11/24 - 10:22 pm
biotech
layoffs
Genentech
Sanofi
Novartis
Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader
Fierce Biotech
Thu, 04/11/24 - 11:56 am
Novartis
Arvinas
protein degradation
prostate cancer
Novartis begins tender offer for cancer-focused MorphoSys
Reuters
Thu, 04/11/24 - 11:54 am
Novartis
M&A
cancer
MorphoSys
Novartis pauses enrollment in some Kisqali trials to fix manufacturing
BioPharma Dive
Wed, 04/10/24 - 05:28 pm
Novartis
Kisqali
drug manufacturing
breast cancer
clinical trials
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell
Novartis to cut 680 jobs in product development
Reuters
Tue, 04/9/24 - 11:09 am
Novartis
layoffs
drug development
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data
BioSpace
Fri, 04/5/24 - 11:37 am
Novartis
Pluvicto
prostate cancer
clinical trials
radioligands
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice
Fierce Pharma
Tue, 03/26/24 - 04:26 pm
China
Pharma CEOs
AstraZeneca
Bayer
Bristol Myers Squibb
GSK
Novartis
Pfizer
Takeda
Ex-Novartis exec sets out to create ‘Apple of AI’
Pharma Voice
Mon, 03/18/24 - 05:12 pm
artificial intelligence
Aily Labs
Novartis
generative AI
Bianca Anghelina

Pages